2 completed. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
Follow elesclomol: new trials by email Literature Review of elesclomol trials Research Report on elesclomol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma STA-4783, Paclitaxel - Melanoma | Phase 1 / Phase 2 | Completed | Synta Pharmaceuticals Corp. | 103 | 2004-05-01 | 2014-03-06 |
| STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) Paclitaxel, Carboplatin, STA 4783 - Stage IIIB Non-Small Cell Lung Cancer, Stage IV Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | Completed | Synta Pharmaceuticals Corp. | 86 | 2004-03-01 | 2008-12-04 |
Carcinoma, Non-Small-Cell Lung (1) · Melanoma (1) · Neoplasm Metastasis (1)
Synta Pharmaceuticals Corp. (2)
United States (2)